Table 1 Baseline Characteristics

Number of eyes

19

20

25

Mean Age (± SD)

66.75 ± 9.7

73.05 ± 14.9

72.68 ± 9.8

0.33

0.38

0.88

Age (Range)

52–83

38–91

49–93

Sex (% Female)

63

55

48

0.32

0.60

0.64

IOP (mmHg ± SD)

14.30 ± 4.2

18.37 ± 4.6

15.78 ± 4.7

0.45

0.02

0.11

Medications (± SD)

1.75 ± 1.30

3.37 ± 1.30

2.84 ± 1.30

0.13

 < 0.01^*

0.20

Visual Acuity (± SD)

0.68 ± 0.54

0.84 ± 0.98

0.33 ± 0.23

0.20

0.80

0.57

Mean Follow-up Time (± SD) (days)

112.82 ± 7.87

256.39 ± 42.33

215.27 ± 34.36

0.01^*

0.01^*

0.67

Type of Glaucoma, N (%)

 Ocular hypertension

0 (0)

0 (0)

1 (4)

n/a

n/a

n/a

 POAG

8 (42)

5 (25)

12 (48)

0.04^*

0.25

1

 PXG

2 (11)

0 (0)

2 (8)

0.82

n/a

n/a

 Pigmentary

1 (5)

0 (0)

2 (8)

n/a

n/a

n/a

 NTG

1 (5)

0 (0)

0 (0)

n/a

n/a

n/a

 MMG

5 (26)

8 (40)

3 (12)

n/a

n/a

0.09

 CACG

2 (11)

7 (35)

5 (20)

0.45

0.22

0.56

Severity of Glaucoma, N (%)

 Ocular hypertension

0 (0)

0 (0)

1 (4)

n/a

n/a

n/a

 Mild

0 (0)

2 (11)

6 (24)

n/a

n/a

n/a

 Moderate

4 (8)

6 (26)

10 (40)

0.32

0.45

0.53

 Severe

15 (92)

12 (63)

8 (32)

 < 0.01^*

0.03^*

0.28